an N-terminal ring domain, followed by two zinc finger motifs, and a C-terminal substrate binding domain (SBD) . The ring domain is the catalytic domain that recruits E2 ubiquitin-conjugating enzymes, while the SBD mediates the binding of adaptor proteins or some Siah substrate proteins. The structure of murine Siah1a SBD has been solved. The structure reveals that Siah is a dimeric protein, and the SBD adopts an eightstranded beta-sandwich fold (Polekhina et al., 2001 ). The substrate binding groove is formed by the betasandwich fold and the beta-strand that connects to the second zinc finger domain (House et al., 2005) .
Expression
Siah2 mRNA is widely expressed in the embryonic and adult mouse tissues. It is expressed at a higher level in the olfactory epithelium, retina, forebrain and proliferating cartilage of developing bone (Della et al., 1993) . Siah2 mRNA is also expressed in most human tissues (Hu et al., 1997) .
Localisation
Siah protein can be localized in both cytoplasm and nucleus.
Domains of human Siah2 protein.
Function
Siah2 is the mammalian homolog of Drosophila SINA (seven in absentia), which interacts with transcriptional repressor Tramtrack via adaptor protein PHYL (Phyllopod) and induces the proteasomal degradation of Tramtrack, thereby determining R7 cell fate (Li et al., 1997; Tang et al., 1997) . As a ring-finger E3 ubiquitin ligase, Siah targets the degradation of diverse substrates via ubiquitin-proteasome pathway, and affects multiple signaling pathways such as HIF (Nakayama et al., 2004) , Ras (Nadeau et al., 2007; Schmidt et al., 2007) , NF-kB (Polekhina et al., 2002; Habelhah et al., 2002) , and beta-catenin (Liu et al., 2001; Matsuzawa and Reed, 2001 ). Siah2 transcription is upregulated by hypoxia (Nakayama et al., 2004) ; p38-mediated phosphorylation of mouse Siah2 on Thr24 and Ser29 alters its subcellular localization (Khurana et al., 2006) ; HIPK2-mediated phosphorylation of human Siah2 on Thr 26, Ser 28 and Ser 68 decreases the stability of Siah2 and impairs its interaction with HIPK2 (Calzado et al., 2009 ). Over 20 Siah substrates have been reported (Nakayama et al., 2009 ) and some of them can be degradated by Siah2, Siah1 or both of them. In contrast to Siah1a knockout mice which exibit growth retardation and spermatogenesis defect, Siah2 knockout mice display no apparent phenotype, whereas Siah2 and Siah1a double knockout mice are embryonic or neonatal lethal, suggesting that the two Siah homologs have both overlapping and distinct functions in vivo (Frew et al., 2003) . Despite the diverse substrates of Siah identified in vitro, loss of Siah2 (or both Siah2 and Siah1a) in vivo largely has no effect on the levels of many Siah substrates and the physiological processes associated with these substrates Frew et al., 2003) . Siah2 is implicated in the regulation of hypoxia response through its effect on HIF prolyl hydroxylases or HIPK2 (Nakayama et al., 2004; Calzado et al., 2009 ). Siah2 knockout mice subject to hypoxia showed impaired respiratory response and defect to adjust levels of red blood cells (Nakayama et al., 2004) . Siah2 has been shown to be required for development and progression of several types of cancers via its regulation of HIF or Ras pathways ). Siah2-dependent degradation of Pard3A is found to control germinal zone exit of neuronal progenitors or immature neurons in mice (Famulski et al., 2010) .
Homology
Homologs: Human has two Siah genes (Siah1 and Siah2) (Hu et al., 1997) , while mouse has three Siah genes (Siah2, Siah1a, Siah1b) (Della et al., 1993) . Human Siah2 shares 77% identity with human Siah1 (Hu et al., 1997) . Orthologs: Highly conserved Siah2 orthologs have been identified in all multicellular organisms examined (Nakayama et al., 2009 ).
Mutations
Note No SIAH2 mutations have been reported.
Implicated in

Lung cancer
Note Ahmed et al. showed that Siah2 knockdown in human lung cancer cell lines (BZR, A549, H727, and UMC11) inhibited MAPK-ERK signaling, reduced cell proliferation and increased apoptosis; Siah2 knockdown also reduced anchorage-independent growth of A549 cells in soft agar, and blocked the growth of A549 xenograft tumors in nude mice (Ahmed et al., 2007) . Note Qi et al. showed that inhibition of Siah2 activity using different inhibitory proteins blocked tumor formation or metastasis of SW1 melanoma cells in a syngeneic mouse model due to the inhibition of Ras and HIF pathways, respectively (Qi et al., 2008) . Similary, Shah et al. showed that a putative chemical inhibitor of Siah2, menadione, decreased the levels of HIF-1alpha and phospho-ERK in human melanoma cell line UACC903 and abolished the growth of xenograft tumor in nude mice (Shah et al., 2009 ). Note Möller et al. showed that inhibition of Siah in a mouse breast cancer cell line reduced the xenograft tumor growth and prolonged the survival of mice due to inhibition of HIF pathway Qi J, Ronai Z Atlas Genet Cytogenet Oncol Haematol. 2011; 15(8) patients of ductal carcinoma in situ (DCIS). Higher level of Siah staining was observed in tumors compared with the normal adjacent tissues, and in tumors with more aggressive features. There was also higher Siah staining in specimens from patients with recurrence as compared to patients without recurrence. This study stuggests that Siah may serve as a prognostic biomarker that predicts DCIS progression to invasive breast cancer (Behling et al., 2010) .
Melanoma
Breast cancer
Pancreatic cancer
Note Schmidt et al. showed that inhibition of Siah activity attenuated MAPK-ERK signaling, blocked RASinduced focus formation in fibroblasts, abolished anchorage-independent growth of human pancreatic cancer cells in soft agar and xenograft tumor growth in nude mice (Schmidt et al., 2008) .
Prostate cancer
Note Qi et al. showed that knockout of Siah2 in the TRAMP model abolished the formation of prostate neuroendocrine tumor, inhibition of Siah2 activity blocked hypoxia-induced neuroendocrine differentiation (NED) in prostate cancer cells or in the xenogaft tumors, and Siah2 protein levels were higher in high-grade PCa that expresss NE markers. This study suggests that Siah2 plays a key role in development of prostate NE tumor and NED of human PCa by controling a cooperation between HIF and NEspecific transcription factor FoxA2 (Qi et al., 2010) .
Breakpoints
Note
There is no breakpoint reported.
